ExploreWatchlistsPricing
  1. JP-listed companies
  2. WAKAMOTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Cost of revenue

WAKAMOTO PHARMACEUTICAL CO.,LTD. (4512)

Market cap
¥11.8B
P/E ratio
51.4x
Wakamoto Pharmaceutical manufactures branded drugs, generic medicines, and health products like Koryoku Wakamoto for healthcare providers and consumers in Japan and internationally.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCost of revenue (Million JPY)YoY (%)
Mar 31, 20265,176+24.22%
Mar 31, 20254,167+0.68%
Mar 31, 20244,139-9.09%
Mar 31, 20234,552+13.04%
Mar 31, 20224,027-8.62%
Mar 31, 20214,407-6.71%
Mar 31, 20204,724+2.18%
Mar 31, 20194,623-4.00%
Mar 31, 20184,816-3.18%
Mar 31, 20174,974+1.17%
Mar 31, 20164,916+2.96%
Mar 31, 20154,775

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat